A client with chronic renal failure is experiencing fluid overload and hypertension. Which medication should the nurse anticipate being prescribed to address these complications?
Angiotensin-converting enzyme (ACE. inhibitor
Phosphate binder
Erythropoietin-stimulating agent (ESA.
Potassium-sparing diuretic
The Correct Answer is A
A. Correct. ACE inhibitors are commonly prescribed to manage hypertension and fluid overload in clients with chronic renal failure. These medications help relax blood vessels, reduce fluid retention, and lower blood pressure.
B. Incorrect. Phosphate binders are prescribed to control phosphate levels, but they do not directly address fluid overload and hypertension.
C. Incorrect. Erythropoietin-stimulating agents (ESA. are used to manage anemia in chronic renal failure and do not specifically address hypertension or fluid overload.
D. Incorrect. Potassium-sparing diuretics may not be the first for managing fluid overload and hypertension in chronic renal failure, especially if the client has elevated potassium levels. ACE inhibitors are a more suitable option in this scenario.
QUESTIONS
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A. Incorrect. Calcium-based phosphate binders should not be taken with milk or calcium-rich foods, as this can lead to an excessive calcium load and increase the risk of hypercalcemia.
B. Incorrect. Calcium-based phosphate binders are most effective when taken with meals to bind to dietary phosphorus.
C. Incorrect. While vitamin D plays a role in calcium metabolism, its supplementation is not directly related to the use of calcium-based phosphate binders.
D. Correct. Constipation is a common side effect of calcium-based phosphate binders. Increasing fluid intake can help alleviate constipation and promote bowel regularity.
Questions
Correct Answer is B
Explanation
A. Incorrect. ESA therapy is not directly related to dehydration or thirst. It is used to manage anemia by stimulating red blood cell production.
B. Correct. ESA therapy can increase red blood cell production, which may elevate blood pressure. Regular blood pressure monitoring is essential to ensure it remains within a safe range.
C. Incorrect. Increased appetite and weight gain are not typical side effects of ESA therapy.
D. Incorrect. ESA therapy is not associated with an increased risk of bleeding or restrictions on engaging in strenuous activities. It is used to manage anemia and improve overall blood cell counts.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
